Category Archives: News

Josip Heit and GSB Gold Standard Group: G999 Message for Christmas 2020 and the New Year

Dear brothers and sisters, dear families, dear partners, I wish you with all my heart all the best, divine blessings and the strength to transform the special challenges that our human family is facing right now into a victory of spiritual truth and divine values. And this regardless of faith, colour or mindset. The GSB… Read More »

Can You Safely Give Birth at Home?

The question of where and how to give birth is a relatively new one for women. Up until the early 20th century, fewer than 5% of women gave birth in a hospital. In the 1950s the birth of a baby, an event that had once been a family affair and attended by a midwife, became… Read More »

ThomasLloyd appoints Vivienne Maclachlan as Group Chief Financial Officer

London, Zurich, 21st December 2020 – ThomasLloyd has made a significant addition to its executive management team with the appointment of Vivienne Maclachlan as Group Chief Financial Officer. An accomplished British professional with Scottish roots, Ms. Maclachlan will take on the role of Group Chief Financial Officer (CFO) and become a member of the Executive… Read More »

TERRE DES FEMMES breaks the silence about domestic violence during what is supposed to be the most peaceful time of the year

Berlin, December 18th 2020: TERRE DES FEMMES – Menschenrechte für die Frau e. V. opens the art exhibition “UNBREAK – take a closer look & break the cycle of domestic violence” (https://cloud.achtung.de/s/g7PanPkDDnf28pe) in downtown Munich, together with the agencies thjnk and achtung! Mary, the artist Simon Berger, and the long-time TERRE DES FEMMES activist Romy… Read More »

People with NNRTI resistance have poorer responses to dolutegravir, South African study finds

People with HIV who already have resistance to a non-nucleoside reverse transcriptase inhibitor (NNRTI) when they start first-line antiretroviral treatment containing the integrase inhibitor dolutegravir were less likely to achieve viral suppression, a large clinical trial in South Africa has reported. NNRTI resistance has not been shown to affect responses to dolutegravir-based treatment previously. The… Read More »